Biomaterials Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Biomaterials Market is Segmented by Type of Biomaterial (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, and Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Dental, Plastic Surgery, and Other Applications), and Geography (North America, Europe, South America, Asia-Pacific and the Middle East and Africa). The Values are Provided in Terms of (In USD) for the Above Segments.

Biomaterials Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Biomaterials Market Size

Biomaterials
Study Period 2019 - 2030
Market Size (2025) USD 202.37 Billion
Market Size (2030) USD 384.37 Billion
CAGR (2025 - 2030) 13.69 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Biomaterials Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Biomaterials Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Biomaterials Market Analysis

The Biomaterials Market size is estimated at USD 202.37 billion in 2025, and is expected to reach USD 384.37 billion by 2030, at a CAGR of 13.69% during the forecast period (2025-2030).

The biomaterials industry is experiencing significant transformation driven by global demographic shifts and increasing healthcare demands. The aging population and rising prevalence of chronic conditions are creating unprecedented demand for advanced medical solutions. According to the International Diabetes Federation's November 2022 report, approximately 537 million adults worldwide were living with diabetes in 2021, with projections indicating an increase to 643 million by 2030. This demographic shift has prompted healthcare providers and manufacturers to develop more sophisticated and biocompatible materials for various medical applications, particularly in chronic disease management and preventive care.


Technological convergence between materials science and biotechnology is revolutionizing the biomaterials landscape. Advanced manufacturing techniques, particularly 3D bioprinting and nanotechnology, are enabling the development of more sophisticated and customized biomaterials solutions. The integration of smart polymeric medical biomaterials, capable of responding to physiological parameters and external stimuli, represents a significant advancement in modern medicine. These materials are increasingly being utilized in regenerative medicine applications, tissue engineering, and targeted drug delivery systems, demonstrating the industry's shift toward more personalized healthcare solutions.


The industry is witnessing substantial investments in research and development, particularly in regenerative medicine and tissue engineering. According to the CDC's May 2023 data, approximately 300,000 older people are hospitalized annually for hip fractures in the United States, while about 3 million elderly people receive emergency treatment for fall injuries each year. These statistics have driven increased focus on developing advanced orthopedic biomaterials and implants. Research institutions and companies are collaborating to develop novel biomaterials that can better integrate with host tissues and promote natural healing processes.


The regulatory landscape continues to evolve, with increasing emphasis on sustainability and environmental impact. Manufacturers are investing in eco-friendly production processes and biodegradable materials to align with global sustainability initiatives. Recent data from Destatis in January 2023 reported approximately 29,000 traffic accident injuries in Germany in November 2022, highlighting the ongoing need for trauma-related medical device materials applications. This has led to increased focus on developing biocompatible materials that not only meet regulatory requirements but also address the growing demand for sustainable healthcare solutions while maintaining high safety and efficacy standards.

Segment Analysis: By Type of Biomaterial

Ceramic Biomaterial Segment in Biomaterials Market

The ceramic biomaterials segment continues to dominate the global biomaterials market, holding approximately 38% market share in 2024. This significant market position is primarily driven by the segment's extensive applications in articulating surfaces in joints and teeth, as well as bone bonding surfaces in implants. Ceramic biomaterials are particularly preferred due to their superior hardness and wear resistance properties, making them ideal for dental and orthopedic applications. The increasing adoption of ceramic biomaterials in joint/tissue replacement, metal coating to improve biocompatibility, and resorbable lattice applications has further strengthened their market position. Major companies like Royal DSM have expanded their premium bio-ceramic materials portfolio for various applications, including orthopedics, sports medicine, and general surgery, contributing to the segment's market leadership.

Market Analysis of Biomaterials Market: Chart for By Type of Biomaterial

Polymeric Biomaterial Segment in Biomaterials Market

The polymeric biomaterials segment is emerging as the fastest-growing segment in the biomaterials market, projected to experience robust growth from 2024 to 2029. This exceptional growth is driven by the increasing application of polymeric biomaterials in tissue engineering, where they play a crucial role in developing new functional tissue and regenerating existing tissue. The segment's growth is further supported by their extensive use in implants, drug delivery biomaterials systems, surgical devices, ocular devices, and orthopedic applications. Polymeric biomaterials are gaining significant traction in cardiology applications, particularly as cardiovascular diseases remain among the leading causes of death globally. Their versatility in developing soft-tissue applications, such as plastic surgeries, and their growing use in ophthalmic implants for contact lenses, intraocular lenses, and glaucoma stents, continue to drive their rapid market expansion.

Remaining Segments in Biomaterials Market by Type

The natural biomaterials and metallic biomaterials segments continue to play vital roles in the biomaterials market. Natural biomaterials are increasingly valued for their biocompatibility and effectiveness in tissue regeneration applications, particularly in heart valves, heart transplants, and bypass grafts. These materials, including fibrin, hyaluronic acid, collagen, and silk, are essential in various advanced medical technologies. Meanwhile, the metallic biomaterials segment maintains its strong presence through applications in joint replacements, dental implants, and orthopedic fixations, benefiting from the materials' high mechanical strength and fracture toughness. Both segments continue to evolve with technological advancements and expanding applications in the medical field.

Segment Analysis: By Application

Cardiology Segment in Biomaterials Market

The Cardiology segment continues to dominate the global biomaterials market, holding approximately 32% market share in 2024. This significant market position is driven by the increasing prevalence of cardiovascular diseases globally and the extensive use of cardiovascular biomaterials in various cardiac applications. Biomaterials are commonly utilized in synthetic blood vessels, artificial hearts, cardiac pacemakers, and other cardiovascular applications. Both natural and synthetic biomaterials exhibit great potential in cardiac repair and regeneration, with materials like gelatin, collagen, alginate, and chitosan being widely used as injectable hydrogels or patches. The segment's growth is further supported by technological advancements in polymeric materials such as polyurethanes, hydrophobic-coated silicon, and fluorine, which are crucial for developing cardiovascular implants and devices. Additionally, the increasing adoption of stem cell therapies in cardiovascular treatments, combined with biomaterial scaffolds, is contributing to the segment's market leadership.

Tissue Engineering Segment in Biomaterials Market

The Tissue Engineering segment is emerging as the fastest-growing segment in the biomaterials market, with an expected growth rate of approximately 17% during 2024-2029. This remarkable growth is driven by significant advances in regenerative medicine and the crucial role of biomaterials in promoting cell growth and differentiation for tissue healing. The segment's expansion is supported by the development of various scaffolds using natural and synthetic biomaterials, including polymers, ceramics, metals, composites, and hydrogels. Recent innovations in polymeric scaffolds have gained particular attention due to their unique properties such as high surface-to-volume ratio, high porosity with very small pore size, biodegradation capabilities, and customizable mechanical properties. The integration of nanobiotechnology with tissue engineering strategies has emerged as an innovative and promising technique, further accelerating the segment's growth potential in regenerative medical science.

Remaining Segments in Biomaterials Market by Application

The biomaterials market encompasses several other significant segments including Orthopedics, Ophthalmology, Plastic Surgery, Dental, Wound Care, and Neurology. The Orthopedics segment maintains a strong presence due to the increasing demand for joint replacements and bone grafts, highlighting the importance of orthopedic biomaterials. Ophthalmology applications focus on corneal implants and other vision-restoration devices, while the Plastic Surgery segment is driven by the growing demand for reconstructive and cosmetic procedures. The Dental segment continues to evolve with innovative dental biomaterials and materials, while Wound Care applications benefit from advanced biomaterial-based dressings and healing solutions. The Neurology segment shows promise in developing treatments for nervous system disorders, with biomaterials being used in neural tissue engineering and drug delivery systems. Each of these segments contributes uniquely to the market's diversity and growth potential.

Biomaterials Market Geography Segment Analysis

Biomaterials Market in North America

North America represents the largest regional biomaterials market globally, driven by advanced healthcare infrastructure, high adoption of innovative medical technologies, and substantial research and development activities. The United States dominates the regional landscape, followed by Canada and Mexico. The presence of major biomaterial manufacturers, increasing chronic diseases, and growing demand for implantable devices contribute significantly to biomaterials market growth. Public and private agencies actively promote biomaterial usage through events and funding initiatives, while technological advancements in tissue engineering and regenerative medicine further boost biomaterials market development.

Market Analysis of Biomaterials Market: Forecasted Growth Rate by Region

Biomaterials Market in the United States

The United States leads the North American biomaterials market, holding approximately 41% of the global biomaterials market share. As a pioneer in bioengineering medical devices and implants, the country benefits from substantial funding through the National Institutes of Health (NIH) and numerous research institutions. The US healthcare infrastructure demonstrates high acceptability for biomaterial-based products, particularly in cardiovascular applications, orthopedics, and dental procedures. Strict FDA regulations ensure product safety and effectiveness, while technological advancements in bioinert, bioactive, and bioabsorbable materials continue to drive innovation in the sector.

Biomaterials Market in Canada

Canada emerges as the fastest-growing market in North America, with a projected growth rate of approximately 13% from 2024-2029. The country's biomaterials market benefits from increasing pharmaceutical and biotechnology industries, alongside an expanding network of research and clinical applications. The government's substantial investments in research infrastructure, including the Biomaterials and Nanomedicine Laboratory initiatives, foster innovation in the field. Canadian companies are particularly active in developing advanced biomaterial solutions for tissue engineering and wound healing applications, while collaboration between industry players and government funding programs accelerates biomaterials market growth.

Biomaterials Market in Europe

Europe represents a significant biomaterials market, characterized by robust research infrastructure, technological innovation, and strong healthcare systems. The region benefits from extensive collaboration between academic institutions, research organizations, and industry players. Germany, France, and the United Kingdom lead the market, while Italy and Spain demonstrate steady growth. The European market is particularly strong in regenerative medicine, tissue engineering, and advanced biomaterial applications for medical devices.

Biomaterials Market in Germany

Germany maintains its position as the largest biomaterials market in Europe, commanding approximately 28% of the regional market share. The country's leadership is supported by its innovative healthcare sector, substantial financial backing, and highly export-intensive medical technology industry. German research and development in tissue engineering and biomaterials market research occupy a dominant position in international comparison, particularly in regenerative medicine activities. The presence of major local players and a strong focus on research and development continue to drive biomaterials market growth.

Biomaterials Market in France

France demonstrates the highest growth potential in the European biomaterials market, with a projected growth rate of approximately 14% from 2024-2029. The country's market is driven by an increasing geriatric population, rising prevalence of chronic diseases, and the presence of various research organizations. French institutions focus extensively on implant research and tissue engineering, supported by increasing funding and grants. The country's sophisticated healthcare infrastructure and strong focus on research and development in the biomaterials market contribute to its rapid market expansion.

Biomaterials Market in Asia-Pacific

The Asia-Pacific biomaterials market demonstrates robust growth potential, driven by increasing healthcare expenditure, growing medical tourism, and rising adoption of advanced medical technologies. The region benefits from the presence of several local manufacturers developing cost-effective biomaterial products, particularly in China and India. Japan's technological expertise, Australia's research capabilities, and South Korea's innovative healthcare sector contribute to the region's dynamic biomaterials market landscape.

Biomaterials Market in China

China dominates the Asia-Pacific biomaterials market, leveraging its large manufacturing base and increasing healthcare investments. The country's biomaterials market sector benefits from government support, growing domestic demand, and an expanding medical device industry. Chinese manufacturers focus on developing cost-effective biomaterial products while maintaining quality standards, making them competitive in both domestic and international markets.

Biomaterials Market in India

India emerges as the fastest-growing market in the Asia-Pacific region, driven by expanding healthcare infrastructure and increasing research activities in the biomaterials market. The country's growth is supported by multiple research labs working on drug delivery systems and tissue regeneration technologies. Indian manufacturers are increasingly focusing on developing innovative biomaterial solutions, particularly in orthopedic and dental applications, while government initiatives support biomaterials market expansion.

Biomaterials Market in Middle East & Africa

The Middle East & Africa biomaterials market shows steady growth potential, with GCC countries and South Africa leading regional development. The market benefits from improving healthcare infrastructure, increasing medical tourism, and growing awareness about advanced medical technologies. While GCC countries emerge as the largest market due to substantial healthcare investments and advanced medical facilities, South Africa demonstrates the fastest growth potential driven by increasing research activities and growing demand for biomaterial-based medical devices.

Biomaterials Market in South America

The South American biomaterials market continues to evolve, with Brazil and Argentina emerging as key markets in the region. Brazil leads the regional market due to its extensive healthcare infrastructure and ongoing research and development activities, while Argentina shows promising growth potential through its sophisticated healthcare system and increasing focus on innovative medical technologies. The region's market is characterized by growing awareness of advanced medical technologies and increasing investment in healthcare infrastructure.

Biomaterials Industry Overview

Top Companies in Biomaterials Market

The global biomaterials market features prominent players including BASF SE, Corbion NV, Zimmer Biomet Holdings Inc., Bayer AG, Victrex PLC, Carpenter Technology Corporation, Noble Biomaterials Inc., Royal DSM, Dentsply Sirona, and Berkeley Advanced Biomaterials Inc. These companies are heavily investing in research and development to create innovative biomaterials solutions across medical, dental, and tissue engineering applications. The industry is characterized by strategic collaborations between manufacturers and research institutions to develop novel biocompatible materials with enhanced properties. Companies are expanding their geographical presence through acquisitions and partnerships, particularly in emerging markets. Operational agility is demonstrated through investments in advanced manufacturing capabilities and the development of specialized production facilities. Product innovation focuses on developing biomedical materials with improved functionality, particularly in areas such as orthopedics, cardiovascular applications, and wound care.

Market Structure Shows Strategic Consolidation Patterns

The biomaterials market exhibits a mix of large diversified conglomerates and specialized manufacturers, with global players dominating the high-end medical applications segment while regional players focus on specific geographic markets or application niches. The industry structure is characterized by vertical integration, with many leading companies controlling their supply chains from raw material procurement to final product distribution. Market consolidation is primarily driven by larger companies acquiring smaller innovative firms to expand their product portfolios and technological capabilities, particularly in emerging biomaterial categories such as tissue engineering and regenerative medicine. The competitive dynamics are further shaped by long-term partnerships between manufacturers and healthcare providers, creating high barriers to entry for new market participants.


The market demonstrates a pattern of strategic alliances and joint ventures, particularly in developing regions where local manufacturing capabilities are combined with global technological expertise. Companies are increasingly focusing on developing specialized biomaterials solutions for specific medical applications, leading to market segmentation based on end-use applications and material types. The competitive landscape is further influenced by regulatory requirements and quality standards, which vary across regions and create distinct market entry barriers. Manufacturing capabilities and intellectual property rights play crucial roles in determining competitive positions, with established players maintaining their market share through patent protection and proprietary technologies.

Innovation and Adaptability Drive Future Success

Success in the biomaterials market increasingly depends on companies' ability to develop innovative solutions while maintaining regulatory compliance and cost competitiveness. Market leaders are strengthening their positions through continuous investment in research and development, focusing on next-generation biomaterials with enhanced functionality and biocompatibility. Companies are also expanding their presence in emerging markets through strategic partnerships and local manufacturing facilities. The ability to adapt to changing healthcare needs and regulatory requirements while maintaining product quality and safety standards is becoming increasingly critical for market success. Successful companies are those that can effectively balance innovation with operational efficiency, while maintaining strong relationships with healthcare providers and research institutions.


For new entrants and smaller players, success lies in identifying and focusing on specific market niches where they can develop specialized expertise and competitive advantages. Companies need to consider the increasing concentration of healthcare providers and their growing influence on product selection and pricing. The threat of substitution remains relatively low due to the specialized nature of biomaterials and stringent regulatory requirements, but companies must continue to innovate to maintain their market positions. Future success will also depend on the ability to navigate complex regulatory environments across different regions while maintaining cost-effective manufacturing operations. Companies that can effectively address sustainability concerns while meeting performance requirements will likely gain competitive advantages in the evolving market landscape.

Biomaterials Market Leaders

  1. Koninklijke DSM N.V.

  2. Corbion NV

  3. Noble Biomaterials, Inc.

  4. Dentsply Sirona

  5. Zimmer Biomet

  6. *Disclaimer: Major Players sorted in no particular order
Biomaterials Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Biomaterials Market News

  • April 2023: ZimVie Inc. announced the recent launches of 2 additions to its biomaterial portfolio: the RegenerOss CC Allograft Particulate, a natural blend of cortical and cancellous bone particles that can be used to fill bony voids in a variety of dental applications, and the RegenerOss Bone Graft Plug, an easy-to-use grafting solution for filling extraction sockets and periodontal defects.
  • March 2023: Botiss Biomaterials GmbH received European CE approval for its dental magnesium biomaterial in the field of dentistry, having an ideal mix of properties suited for tissue regeneration.

Biomaterials Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 New Innovations in the Field of Biomaterials
    • 4.2.2 Increasing Implant Devices and Plastic Surgery Market
    • 4.2.3 Increasing Applications of Biomaterials in Wound Care/Sports Injury
  • 4.3 Market Restraints
    • 4.3.1 Compatibility Issues
    • 4.3.2 Stringent Regulatory Guidelines
    • 4.3.3 High Price of the Implantable Biomaterials
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value USD million)

  • 5.1 By Type of Biomaterial
    • 5.1.1 Natural Biomaterial
    • 5.1.2 Metallic Biomaterial
    • 5.1.3 Ceramic Biomaterial
    • 5.1.4 Polymeric Biomaterial
  • 5.2 By Application
    • 5.2.1 Neurology
    • 5.2.2 Cardiology
    • 5.2.3 Orthopedics
    • 5.2.4 Ophthalmology
    • 5.2.5 Wound Care
    • 5.2.6 Dental
    • 5.2.7 Plastic Surgery
    • 5.2.8 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 BASF SE
    • 6.1.2 Dentsply Sirona
    • 6.1.3 Noble Biomaterials Inc.
    • 6.1.4 Zimmer Biomet
    • 6.1.5 Carpenter Technology Corporation
    • 6.1.6 Cam Bioceramics
    • 6.1.7 Koninklijke DSM N.V.
    • 6.1.8 Corbion NV
    • 6.1.9 Berkeley Advanced Biomaterials Inc.
    • 6.1.10 Victrex PLC
    • 6.1.11 Bezwada Biomedical LLC
    • 6.1.12 Collagen Solutions LLC
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Biomaterials Industry Segmentation

As per the scope of the report, biomaterials are substances that have been engineered to interact with biological systems for a medical purpose, either a therapeutic (treat, augment, repair, or replace a tissue function of the body) or a diagnostic one. 

The biomaterials market is segmented by type of biomaterial (natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial), application (neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications), and geography (North America, Europe, South America, Asia-Pacific and the Middle East and Africa). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (USD) for all the above segments.

By Type of Biomaterial Natural Biomaterial
Metallic Biomaterial
Ceramic Biomaterial
Polymeric Biomaterial
By Application Neurology
Cardiology
Orthopedics
Ophthalmology
Wound Care
Dental
Plastic Surgery
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Biomaterials Market Research Faqs

How big is the Biomaterials Market?

The Biomaterials Market size is expected to reach USD 202.37 billion in 2025 and grow at a CAGR of 13.69% to reach USD 384.37 billion by 2030.

What is the current Biomaterials Market size?

In 2025, the Biomaterials Market size is expected to reach USD 202.37 billion.

Who are the key players in Biomaterials Market?

Koninklijke DSM N.V., Corbion NV, Noble Biomaterials, Inc., Dentsply Sirona and Zimmer Biomet are the major companies operating in the Biomaterials Market.

Which is the fastest growing region in Biomaterials Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Biomaterials Market?

In 2025, the North America accounts for the largest market share in Biomaterials Market.

What years does this Biomaterials Market cover, and what was the market size in 2024?

In 2024, the Biomaterials Market size was estimated at USD 174.67 billion. The report covers the Biomaterials Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biomaterials Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Biomaterials Market Research

Mordor Intelligence provides a comprehensive analysis of the biomaterials industry. We leverage our extensive expertise in biomedical materials research and consulting. Our latest report examines the evolving landscape of biodegradable materials and bioactive materials. It encompasses both natural biomaterials and synthetic biomaterials. The analysis covers key segments, including ceramic biomaterials, polymeric biomaterials, and metallic biomaterials. Detailed insights are available in an easy-to-read report PDF format for download. Our research thoroughly examines bone graft materials, dental biomaterials, and cardiovascular biomaterials, providing stakeholders with crucial insights into market dynamics.

The report offers invaluable intelligence for stakeholders across the biocompatible materials value chain. This includes manufacturers of medical device materials and developers of drug delivery biomaterials. Our analysis encompasses emerging applications in tissue engineering materials and implantable materials. We also examine the growing demand for orthopedic biomaterials and bioresorbable materials. The comprehensive coverage includes a detailed assessment of the global biomaterials market size, with a specific focus on medical implant materials and their applications. Stakeholders benefit from our thorough biomaterials market analysis, which provides strategic insights for informed decision-making in this rapidly evolving industry.

Biomaterials Market Report Snapshots